Lanadelumab
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Lanadelumab and local guidelines before prescribing.
Kallikrein inhibitor
Mechanism
Plasma kallikrein inhibitor monoclonal antibody.
Uses
Hereditary angioedema prophylaxis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Injection-site reactions, hypersensitivity, raised APTT.
Interactions
Few.
Contraindications and cautions
Hypersensitivity
Monitoring
Attack frequency
Pregnancy and breastfeeding
Limited data
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
Prophylaxis only, not for acute attacks.
More from the textbook: uses, cautions and other points
- HAE prevention - prophylaxis before surgery or dental work (C1-inhibitor), long-term prophylaxis (lanadelumab, berotralstat); patient-held treatment for attacks.
Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies - Lanadelumab / berotralstat | Long-term prophylaxis in hereditary angioedema.
Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies - Long-term prophylaxis - lanadelumab (plasma kallikrein inhibitor antibody - SC every 2–4 weeks), berotralstat (oral daily), SC or IV C1 inhibitor; older options - danazol, tranexamic acid.
Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema - HAE | Swelling, abdominal attacks, low C4 | C1-INH or icatibant; lanadelumab or berotralstat prophylaxis
Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema - Icatibant or C1 inhibitor for attacks (home therapy); consider long-term prophylaxis (lanadelumab or berotralstat); prophylaxis before dental work; test relatives.
Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema - NICE TA339: Omalizumab for chronic spontaneous urticaria; NICE TA606: Lanadelumab; NICE TA738: Berotralstat
Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema